Urolift vs TURP vs BPH Treatment with Medications vs Dr Allen’s Device

451
URP Urolift

The irritating symptoms of benign prostatic hyperplasia (BPH), namely lower urinary tract symptoms (LUTS), are frequent urination during day and night, trouble starting a urine stream, poor and/or intermittent stream. These LUTS have a negative impact on men and their families.

BPU drugs (alpha-blockers and 5-alpha reductase inhibitors) and minimally invasive surgeries for enlarged prostate, which include transurethral resection of the prostate (TURP), Transurethral electrovaporization of the prostate (TUVP) and UroLift, are always compared to each other for their safety. However, the only option treatment for BPH without side effects is Thermobalancing therapy with Dr Allen’s Device.

Risky Treatments for BPH Should Be Used Very Carefully

Men should know that over one-half of them have BPH by age of 60, and this number increases as men get older, so 90% of men older than 80 have enlarged prostate. It is therefore wrong that men who begin experiencing LUTS are candidates for aggressive treatment with risky medications and various prostate surgeries. 

The 2 groups of BPH drugs used do not treat an affected prostate gland but try to alleviate LUTS. Alpha blockers relax the bladder, helping urinate easily, can develop fatigue, headache, dizziness, and sexual dysfunction. 5-alpha reductase inhibitors are responsible for irreversible side effects: impotence, depression, testicular pain and even diabetes.

Complications of TURP and TUVT include ejaculatory dysfunction, erectile dysfunction, urethral stricture, permanent urinary incontinence. Urolift has fewer complications, but often requires reoperation. The study provided in the Imperial College, London has estimate that the complication rate associated with TURP could be halved with UroLift.

The cost of medical treatment for BPH ranges from US $ 550 to US $ 3500 per year. The overall cost of the TURP procedure may vary from $5,000-$15,000, and UroLift procedure over $6,000.

Dr Allen’s Device Is the Best Solution for Men with BPH

A large clinical study on Thermobalancing therapy, which investigated about 250 men with BPH, has confirmed the effectiveness and safety of Dr Allen’s Device. Empirical evidence strongly suggests that Dr Allen’s device helps men with enlarged prostates in the United States, Australia, the Middle East, and other 100 countries to reduce prostate volume and urinary symptoms without side effects.

Fine Treatment https://finetreatment.com/ is a healthcare company, a manufacturer and distributor of wearable therapeutic Dr Allen’s Devices. Fine Treatment is a UK Department for International Trade (DIT) registered supplier to international buyers. Dr Allen’s device is the most cost-effective solution for BPH, as its price is less than $200.

A scientific article titled “Innovative Thermobalancing therapy and Dr Allen’s Device for the first time employ body energy to treat chronic prostatic diseases effectively”, https://link.springer.com/article/10.1186/s40887-020-00035-0, explains that the cause of BPH is due to poor blood circulation in the prostate gland, which can be improved with Dr Allen’s Device.

Thermobalancing therapy with Dr Allen’s Device was patented by the USPTO. Dr Allen’s Device is a class 1 medical device; therefore, it does not require the involvement of a notified body. The device is registered with The Medicines and Healthcare products Regulatory Agency since 2010. So, every man with BPH can use it day and night without worrying, since the device is safe.